Cytogenetic findings in acute leukaemias of infants.

Por Lampert, F., Harbott, J., Ritterbach, J.
Publicado em 1992

The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods

Por Linka, Y, Ginzel, S, Krüger, M, Novosel, A, Gombert, M, Kremmer, E, Harbott, J, Thiele, R, Borkhardt, A, Landgraf, P
Publicado em 2013

Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.

Por Vormoor, J., Ritter, J., Creutzig, U., Boos, J., Heyen, P., Ludwig, W. D., Harbott, J., Löffler, H., Schellong, G.
Publicado em 1992

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome

Por Harrison, CJ, Moorman, AV, Schwab, C, Carroll, AJ, Raetz, EA, Devidas, M, Strehl, S, Nebral, K, Harbott, J, Teigler-Schlegel, A, Zimmerman, M, Dastuge, N, Baruchel, A, Soulier, J, Auclerc, M-F, Attarbaschi, A, Mann, G, Stark, B, Cazzaniga, G, Chilton, L, Vandenberghe, P, Forestier, E, Haltrich, I, Raimondi, SC, Parihar, M, Bourquin, J-P, Tchinda, J, Haferlach, C, Vora, A, Hunger, SP, Heerema, NA, Haas, OA
Publicado no Leukemia (2013)